Novel pyrazolo[1,5-a]pyrimidine derivatives target CDK2 and CDK7, suggesting potential in anticancer therapies.
A series of novel pyrazolo[1,5- a ]pyramidal derivatives have been developed based on the structural analysis of previously identified CDK2 inhibitors.
No takes yet. Share an insight, caveat, or question.
El-Bakry et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: